BIOMAT Database Logo BIOMAT Database Logo

Rh-o (D) immune globulin (human). Evaluation in women at risk of Rh immunization. 1968

W Q Ascari, and A E Allen, and W J Baker, and W Pollack

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D001789 Blood Group Antigens Sets of cell surface antigens located on BLOOD CELLS. They are usually membrane GLYCOPROTEINS or GLYCOLIPIDS that are antigenically distinguished by their carbohydrate moieties. Blood Group,Blood Group Antigen,Blood Groups,Antigen, Blood Group,Antigens, Blood Group,Group Antigen, Blood,Group, Blood,Groups, Blood
D004899 Erythroblastosis, Fetal A condition characterized by the abnormal presence of ERYTHROBLASTS in the circulation of the FETUS or NEWBORNS. It is a disorder due to BLOOD GROUP INCOMPATIBILITY, such as the maternal alloimmunization by fetal antigen RH FACTORS leading to HEMOLYSIS of ERYTHROCYTES, hemolytic anemia (ANEMIA, HEMOLYTIC), general edema (HYDROPS FETALIS), and SEVERE JAUNDICE IN NEWBORN. Hemolytic Disease of Newborn,Erythroblastosis Fetalis,Erythroblastoses, Fetal,Erythroblastosis Fetali,Fetal Erythroblastoses,Fetal Erythroblastosis,Fetali, Erythroblastosis,Fetalis, Erythroblastosis,Newborn Hemolytic Disease,Newborn Hemolytic Diseases
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age
D012204 Rh-Hr Blood-Group System Erythrocyte isoantigens of the Rh (Rhesus) blood group system, the most complex of all human blood groups. The major antigen Rh or D is the most common cause of erythroblastosis fetalis. Rh Factors,Rhesus Blood-Group System,Antigen D, Rh Blood Group,Blood-Group System, Rh-Hr,Blood-Group System, Rhesus,Blood-Group Systems, Rh-Hr,Blood-Group Systems, Rhesus,Factor, Rh,Factors, Rh,Rh Factor,Rh Hr Blood Group System,Rh-Hr Blood-Group Systems,Rhesus Blood Group System,Rhesus Blood-Group Systems,System, Rh-Hr Blood-Group,System, Rhesus Blood-Group,Systems, Rh-Hr Blood-Group,Systems, Rhesus Blood-Group

Related Publications

W Q Ascari, and A E Allen, and W J Baker, and W Pollack
Preventive of immunization in women at greatest risk using anti-Rh (D) gamma globulin.
June 1969, The Medical journal of Australia,
W Q Ascari, and A E Allen, and W J Baker, and W Pollack
Role of Rh o (D) immune globulin in induced abortions.
March 1971, Clinical obstetrics and gynecology,
W Q Ascari, and A E Allen, and W J Baker, and W Pollack
Single dilution radio-immune assay for the determination of anti-Rh-o (D) content of Rh-o (D) immune globulin.
September 1970, Biochemical and biophysical research communications,
W Q Ascari, and A E Allen, and W J Baker, and W Pollack
The risk of immunization IgG following Rh immune globulin therapy.
January 1974, Transfusion,
W Q Ascari, and A E Allen, and W J Baker, and W Pollack
Antibodies to IGA in pregnancy and in recipient of Rh o (D) immune globulin (human).
January 1972, Transfusion,
W Q Ascari, and A E Allen, and W J Baker, and W Pollack
Detection of fetal maternal hemorrhage: an evaluation of serological tests related to Rh-o(D) immune globulin (human).
January 1971, Transfusion,
W Q Ascari, and A E Allen, and W J Baker, and W Pollack
Intravenous Rh(o) [D] immune globulin [human] (WinRho SDF): suspected hemolytic/renal adverse reactions.
October 2000, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne,
W Q Ascari, and A E Allen, and W J Baker, and W Pollack
Rh(O)D immune globulin products for prevention of alloimmunization during pregnancy.
February 2015, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists,
W Q Ascari, and A E Allen, and W J Baker, and W Pollack
One millilitre injections of Rh (D) immune globulin (human) in prevention of Rh immunization. A further report on the clinical trial.
July 1969, The Medical journal of Australia,
W Q Ascari, and A E Allen, and W J Baker, and W Pollack
Declining Rh(D) Immune Globulin During Pregnancy.
October 2023, NeoReviews,
Copied contents to your clipboard!